NCT03911375

Brief Summary

This study evaluates the influence of stress on inflammation and the symptomatology of the patient with back pain. Mindfulness Based Stress Reduction (MBSR) will be used in half of participants, a validated psychopedagogical intervention for stress reduction, and the participants assigned to the control group will follow the usual treatment, according to their diagnosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

April 3, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 11, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
Last Updated

May 6, 2022

Status Verified

July 1, 2021

Enrollment Period

12 months

First QC Date

April 2, 2019

Last Update Submit

May 5, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Stress change

    Measured with the variation of cortisol in blood. These samples are obtained from a blood test that will be done to the participants before and after starting the experimental and control programs.

    Baseline and Six months

  • Variation of cytokines

    ((TNF) -α and interleukin (IL) -1β, IL-6 and IL17), as an approximate biomarker of inflammation. Bio-chemical markers of the discopathy: Cytokines ((TNF) -α, interleukin (IL) -1β, IL-6 and IL-17). These samples are obtained from a blood test that will be done to the participants before and after starting the experimental and control programs.

    Baseline and Six months

  • Variation of the nocturnal apnea index.

    Sleep and breathing analysis: The performance of the sleep and breathing registration tests will be carried out in the patient's home. The sleep study will be done with a validated respiratory polygraphy (BTI-APNiA®). The sleep analysis will be controlled by a sleep technician and supervised by a sleep medicine specialist. The sleep analysis will be done to the participants before and after starting the experimental and control programs.

    Baseline and Six months

Secondary Outcomes (16)

  • Five Facet Mindfulness Questionnaire (FFMQ)

    Baseline and Six months

  • Self-Compassion Scale (SCS)

    Baseline and Six months

  • Perceived Stress Scale (PSS)

    Baseline and Six months

  • DASS-21

    Baseline and Six months

  • Chronic Pain Grade Scale (CPGS; 90)

    Baseline and Six months

  • +11 more secondary outcomes

Study Arms (2)

Mindfulness Based Stress Reduction (MBSR)

EXPERIMENTAL

Program of 30 hours of duration divided into 9 sessions with a weekly frequency of 2.5 h and an intensive session between week 6 and 7 of the program with a duration of 7.5 hours.

Other: Mindfulness Based Stress Reduction (MBSR)

Control

NO INTERVENTION

Participants assigned to the control group will follow the usual treatment, according to their diagnosis.

Interventions

Psycho-educational program of stress reduction based on mindfulness. Program of 30 hours of duration divided into 9 sessions with a weekly frequency of 2.5 h and an intensive session between week 6 and 7 of the program with a duration of 7.5 hours. Each week the theoretical contents necessary to understand the attention development practices proposed in mindfulness-based interventions will be covered. In addition, basic concepts of the psychobiology and psychology of stress and pain are explained. The subjects will have a homework load of approximately 45 minutes per day during the duration of the intervention.

Mindfulness Based Stress Reduction (MBSR)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be diagnosed with symptomatic disc disease (Participants must provide a medical report that certifies the discopathy).
  • Normal or moderate mobility
  • Normal cognitive state
  • Patients who have previously read and signed the informed consent.
  • Patients that are capable and willing to comply with the study procedures.

You may not qualify if:

  • Serious psychopathologies
  • Suicidal thoughts.
  • Deep depression
  • Psychosis
  • Drug addiction
  • Very limited functional capacity and cognitive impairment: Patientsconfined in a bed or a chair. They need the help of a third person.
  • Do not incorporate during the program any clinical, psychological or pharmacological treatments different from those ones that are normally used to controlled the pain, or any drastic changes in lifestyle.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Fundación Eduardo Anitua

Vitoria-Gasteiz, Alava, 01007, Spain

Location

Instituto de Investigación y Formación en Ciencias Cognitivas - Nirakara

Madrid, Colmenarejo, 28070, Spain

Location

Facultad de Psicología de la Universidad Complutense de Madrid.

Madrid, Somosaguas, 28223, Spain

Location

MeSH Terms

Conditions

Back Pain

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2019

First Posted

April 11, 2019

Study Start

April 3, 2019

Primary Completion

March 30, 2020

Study Completion

March 30, 2020

Last Updated

May 6, 2022

Record last verified: 2021-07

Locations